Iatia MD Cussinet resigns
Thursday, 26 September, 2002
The resignation of Iatia managing director Philippe Cussinet will not impact the growth of the company, according to CEO Brian Powell.
"His departure will certainly not slow down our development or our sales," Powell told Australian Biotechnology News.
Powell said that Cussinet had resigned due to family reasons, effective immediately. He noted that the company had recently appointed a new sales chief who would take over many of Cussinet's responsibilities for expanding the sales and marketing operations.
"I don't think we'll have any hiccups," Powell said. "Of course, we'll miss him like hell."
Powell said that the development and expansion of the company was proceeding according to plan, and the company was investigating the possibility of applying its optical imaging technology in the automotive industry in talks with an automotive manufacturer.
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
